1. The role of external beam radiotherapy in the management of bone metastases;Agarawal;Clinical Oncology,2006
2. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: A randomised, open label, non-inferiority phase 3 trial;Barrett-Lee;Lancet Oncology,2014
3. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma;Berenson;The New England Journal of Medicine,1996
4. Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: Results from two randomised, placebo-controlled phase III studies;Body;British Journal of Cancer,2004
5. A study of the biological receptor activator of nuclear factor-kappa B ligand inhibitor, Denosumab, in patients with multiple myeloma or bone metastases from breast cancer;Body;Clinical Cancer Research,2006